C07C 279/10
Being further substituted by doubly-bound oxygen atoms
Official title: being further substituted by doubly-bound oxygen atoms
C07C279/10 (Being further substituted by doubly-bound oxygen atoms) appears on 19 US grants and 21 published applications in this corpus.
Search patents in C07C- Granted patents
- 19
- Published applications
- 21
- Assignees
- 17
- Inventors
- 75
- Latest grant
- 30 Sep 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1983 | 1 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 3 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 1 |
| 2005 | 0 | 0 |
| 2006 | 0 | 1 |
| 2007 | 0 | 0 |
| 2008 | 1 | 2 |
| 2009 | 2 | 1 |
| 2010 | 0 | 0 |
| 2011 | 0 | 2 |
| 2012 | 0 | 0 |
| 2013 | 1 | 1 |
| 2014 | 0 | 1 |
| 2015 | 0 | 1 |
| 2016 | 2 | 1 |
| 2017 | 1 | 1 |
| 2018 | 0 | 0 |
| 2019 | 0 | 1 |
| 2020 | 1 | 1 |
| 2021 | 2 | 5 |
| 2022 | 0 | 1 |
| 2023 | 1 | 0 |
| 2024 | 2 | 0 |
| 2025 | 1 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- P62 ligand compound, and composition for preventing, ameliorating or treating proteinopathies comprising the same30 Sep 2025US 12,427,346 B2Autotac Inc.
- AUTOTAC chimeric compound, and composition for preventing, ameliorating or treating diseases through targeted protein degradation comprising the same29 Oct 2024US 12,129,218 B2Autotac Inc.
- P62 ligand compound, and composition for preventing, ameliorating or treating proteinopathies comprising the same14 May 2024US 11,981,618 B2Autotac Inc.
- Antimicrobial polymers capable of supramolecular assembly4 Apr 2023US 11,617,367 B2Agency for Science, Technology and Research
- Compositions, methods, and systems for the synthesis and use of imaging agents16 Nov 2021US 11,174,223 B2Lantheus Medical Imaging, Inc.
- Compositions, methods, and systems for the synthesis and use of imaging agents29 May 2025US 2025/0171398 A1Lantheus Medical Imaging, Inc.
- Compositions, methods, and systems for the synthesis and use of imaging agents20 Jan 2022US 2022/0017459 A1Lantheus Medical Imaging, Inc.
- Small molecules targeting mutant mammalian proteins2 Dec 2021US 2021/0371403 A1Jnana Therapeutics Inc.
- Novel p62 ligand compound, and composition for preventing, ameliorating or treating proteinopathies compring the same11 Nov 2021US 2021/0347749 A1Protech SPA
- Novel autotac chimeric compound, and composition for preventing, ameliorating or treating diseases through targeted protein degradation comprising the same30 Sep 2021US 2021/0299253 A1Protech SPA
Most cited
By later US patents
- Aromatic compounds containing basic and acidic termini useful as fibrinogen receptor antagonists30US 5,523,302 AThe Du Pont Merck Pharmaceutical Company · 1996
- Phenalene-1-one derivatives, method for producing same and use thereof12US 9,302,004 B2Trioptotec GmbH · 2016
- Compositions, methods, and systems for the synthesis and use of imaging agents9US 9,388,125 B2Lantheus Medical Imaging, Inc. · 2016
- Substituted derivatives of amino alkane diols as gastric secretion inhibitors8US 4,411,899 AMerck & Co., Inc. · 1983
- Aromatic compounds containing basic and acidic termini useful as fibrinogen receptor antagonists5US 5,739,163 AThe DuPont Merck Pharmaceutical Company · 1998